IRONWOOD PHARMACEUTICALS INC·4

Mar 10, 5:12 PM ET

Rickard Jason 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Mar 10, 2023

Insider Transaction Report

Form 4
Period: 2023-03-08
Rickard Jason
SVP, Chief Operating Officer
Transactions
  • Award

    Class A Common Stock

    2023-03-08+43,668376,316 total
  • Award

    Performance-based Restricted Stock Units

    2023-03-08+21,83421,834 total
    Exp: 2026-02-28Class A Common Stock (21,834 underlying)
Footnotes (2)
  • [F1]The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
  • [F2]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION